Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes.

For: All,

Researchers studied which specific genes within the 16p11.2 region contribute to conditions like autism, schizophrenia, intellectual disability, obesity, and bipolar disorder by analyzing large genetic and health record databases, identifying key genes (such as TMEM219, INO80E, SPN, and TAOK2) linked to specific health outcomes—helping families better understand why carriers of 16p11.2 changes may experience a range of health and developmental challenges.